Acura Pharmaceuticals, Inc. (ACUR) News: Acura Pharmaceuticals' CEO …

Published March 5, 2014

Acura Pharmaceuticals, Inc. (ACUR) news: Acura Pharmaceuticals' CEO …
Now we'll turn to our NEXAFED franchise, NEXAFED is our methamphetamine resistant, non-prescription nasal decongestant containing pseudoephedrine. We launched NEXAFED in December 2012 with the marketing program directed to pharmacists.
Read more on Seeking Alpha

District Attorney pushes for greater use of drug tracking program
They're methamphetamine users who roam from pharmacy to pharmacy to purchase boxes of the decongestant pseudophedrine so their meth “cooks” can make more of the highly addictive drug. Police in Washington County said users buying boxes and …
Read more on Glens Falls Post-Star

More Meth Program Information…